[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Lantern Pharma Inc (LTRN)

Lantern Pharma Inc (LTRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 29,275
  • Shares Outstanding, K 12,784
  • Annual Sales, $ 0 K
  • Annual Income, $ -17,120 K
  • EBIT $ -12 M
  • EBITDA $ -18 M
  • 60-Month Beta 2.34
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A

Options Overview Details

View History
  • Implied Volatility 317.91% (+40.79%)
  • Historical Volatility 59.88%
  • IV Percentile 40%
  • IV Rank 30.78%
  • IV High 857.88% on 02/18/26
  • IV Low 77.80% on 01/30/26
  • Expected Move (DTE 28) 0.00 (0.00%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 25
  • Volume Avg (30-Day) 197
  • Put/Call OI Ratio 0.96
  • Today's Open Interest 1,218
  • Open Int (30-Day) 777
  • Expected Range 2.35 to 2.35

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year $-0.54
  • Growth Rate Est. (year over year) +185,100.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.23 +5.38%
on 08/21/26
2.95 -20.47%
on 07/22/26
-0.59 (-20.07%)
since 07/21/26
3-Month
2.23 +5.38%
on 08/21/26
4.34 -45.85%
on 07/01/26
-0.97 (-29.22%)
since 05/21/26
52-Week
1.11 +111.71%
on 03/27/26
4.70 -50.04%
on 10/08/25
-1.84 (-43.91%)
since 08/21/25

Most Recent Stories

More News
Lantern Pharma Reports Second Quarter 2026 Financial Results and Provides Business Update

Open Medicine AI Established as a Separate Company with Executed Commercial Licenses; Progression-Free Survival Benefit Deepens in EGFR Exon 21 L858R Lung Cancer with LP-300; EMA Clears LP-184, zirdafulven,...

LTRN : 2.30 (+0.44%)
New to The Street Show 766 Broadcasts Tonight at 6:30 PM ET on Bloomberg Television, Featuring BioVie's Bezisterim Parkinson's Disease Clinical Results

Sponsored Programming Also Broadcasts Across Bloomberg Television in Latin America and MENA, Expanding the Global Reach of New to The Street's Featured Companies

CAST : 1.5800 (-15.51%)
RHNO : 8.0000 (unch)
IGC : 0.2873 (+3.64%)
BIVI : 1.9100 (+2.69%)
VTIX : 1.2750 (+2.00%)
LTRN : 2.30 (+0.44%)
BSIN : 1.4200 (+1.43%)
DVLT : 0.3180 (+0.92%)
COCH : 0.7402 (-1.36%)
Lantern Pharma to Report Second Quarter 2026 Operating & Financial Results on August 14th, 2026 at 9:00 a.m. ET

Webcast to be held Friday, August 14th, 9:00 a.m. ET, register for the webcast here , or at the link provided below.

LTRN : 2.30 (+0.44%)
Lantern Pharma (Nasdaq: LTRN) Establishes Open-Medicine AI as a Separate Company to Commercialize and Expand Its Multi-Agent AI Co-Scientist Platform for the Transformation of Medicine

The Open-Medicine AI multi-agentic co-scientist platform represents the strategic evolution of withZeta.ai and is expanding into additional disease areas and modalities. The creation...

LTRN : 2.30 (+0.44%)
New to The Street TV Announces Broadcast of Show No. 765 Tonight on Bloomberg Television at 6:30 PM ET Featuring Envoy Medical, Graphene Manufacturing Group, Rhino Bitcoin, and Big Sky Industrial

Show Also Airs Today Across Latin America and the MENA Region as Sponsored Programming, Featuring Debut Television Commercials from Rhino Bitcoin, PetVivo, Lantern Pharma, Data Vault Holdings AI, and FreeCast...

CAST : 1.5800 (-15.51%)
RHNO : 8.0000 (unch)
PETV : 0.7000 (+4.48%)
GMGMF : 1.5300 (-1.29%)
LTRN : 2.30 (+0.44%)
BSIN : 1.4200 (+1.43%)
DVLT : 0.3180 (+0.92%)
COCH : 0.7402 (-1.36%)
Lantern Pharma to Advance EMA-Cleared Phase 1b/2 Trial of LP-184 (Zirdafulven) in Biomarker-Selected Advanced Bladder Cancer

Investigator-initiated European study will evaluate a distinctive dual-biomarker precision-oncology strategy — PTGR1 overexpression combined with tumor-specific Nucleotide Excision Repair — in patients...

LTRN : 2.30 (+0.44%)
New to The Street to Broadcast Nationwide on Bloomberg Television Tonight at 6:30 PM ET Featuring RHINO Bitcoin, Marina Decisions, Medicus Pharma and Virtuix Holdings

NEW YORK CITY, NY / ACCESS Newswire / July 25, 2026 / New to The Street, one of America's longest-running sponsored business television brands, today announced the broadcast of its latest episode, airing...

CAST : 1.5800 (-15.51%)
RHNO : 8.0000 (unch)
PETV : 0.7000 (+4.48%)
VTIX : 1.2750 (+2.00%)
LTRN : 2.30 (+0.44%)
MDCX : 0.2711 (-0.40%)
BSIN : 1.4200 (+1.43%)
DVLT : 0.3180 (+0.92%)
COCH : 0.7402 (-1.36%)
Lantern Pharma Receives USPTO Notice of Allowance for Patent Covering Biomarker-Guided Treatment with LP-184 (Zirdafulven) in Multiple Solid Tumor Cancers

Allowed patent claims cover the use of a three-gene expression signature — PTGR1, PTPN14, and ASPH — to identify patients for treatment with LP-184 (Zirdafulven) ...

LTRN : 2.30 (+0.44%)
New to The Street(R) to Broadcast Show #762 Tonight on Bloomberg Television at 6:30 PM ET, Featuring Envoy Medical (NASDAQ:COCH), AlphaCompute (NASDAQ:ALP), RHINO Bitcoin (OTC PINK:RHNO), and Big Sky Industrial (NASDAQ:BSIN)

Sponsored Programming Airs Across Bloomberg Television U.S., MENA, and Latin America, Supported by Television Commercials From Lantern Pharma, Datavault AI, Big Sky Industrial, FreeCast, PetVivo Holdings,...

CAST : 1.5800 (-15.51%)
RHNO : 8.0000 (unch)
PETV : 0.7000 (+4.48%)
IGC : 0.2873 (+3.64%)
ALP : 0.1527 (-2.18%)
LTRN : 2.30 (+0.44%)
BSIN : 1.4200 (+1.43%)
DVLT : 0.3180 (+0.92%)
COCH : 0.7402 (-1.36%)
New to The Street Show #761 to Broadcast Across Bloomberg U.S., Latin America and MENA, Featuring Sagtec Global, Virtuix, Lantern Pharma and YY Group

The show broadcasts at 6:30 PM ET as sponsored programming, with television commercials featuring Big Sky Industrial, Envoy Medical, FreeCast and Datavault AI

CAST : 1.5800 (-15.51%)
VTIX : 1.2750 (+2.00%)
LTRN : 2.30 (+0.44%)
YYGH : 1.2100 (+2.54%)
BSIN : 1.4200 (+1.43%)
DVLT : 0.3180 (+0.92%)
SAGT : 0.6659 (+5.88%)
COCH : 0.7402 (-1.36%)

Business Summary

Lantern Pharma Inc.is a biotechnology company. It develops medicines for multi-drug treatment resistance cancers focusing on prostate and ovarian cancers. The company's drug candidate consist LP-100, LP-300 and LP-184 which are in clinical stage. Lantern Pharma Inc.is based in Dallas, Texas.

See More

Key Turning Points

3rd Resistance Point 2.72
2nd Resistance Point 2.62
1st Resistance Point 2.45
Last Price 2.30
1st Support Level 2.19
2nd Support Level 2.09
3rd Support Level 1.92

See More

52-Week High 4.70
Fibonacci 61.8% 3.33
Fibonacci 50% 2.91
Fibonacci 38.2% 2.48
Last Price 2.30
52-Week Low 1.11

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.